- 全部删除
您的购物车当前为空
FMF-04-159-2是一种高效的共价型细胞周期蛋白依赖性激酶14(CDK14)抑制剂,对CDK14和CDK2的IC₅₀分别为39.6 nM和256 nM。FMF-04-159-2能够减少α-突触核蛋白(α-Syn)在神经元中的聚集并在帕金森病模型中发挥作用,也能够通过减弱Wnt/β-catenin信号抑制三阴性乳腺癌(TNBC)的进展和转移。


为众多的药物研发团队赋能,
让新药发现更简单!
FMF-04-159-2是一种高效的共价型细胞周期蛋白依赖性激酶14(CDK14)抑制剂,对CDK14和CDK2的IC₅₀分别为39.6 nM和256 nM。FMF-04-159-2能够减少α-突触核蛋白(α-Syn)在神经元中的聚集并在帕金森病模型中发挥作用,也能够通过减弱Wnt/β-catenin信号抑制三阴性乳腺癌(TNBC)的进展和转移。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 329 | In stock | |
| 5 mg | ¥ 787 | In stock | |
| 10 mg | ¥ 1,380 | In stock | |
| 25 mg | ¥ 2,980 | In stock | |
| 50 mg | ¥ 4,290 | In stock | |
| 100 mg | ¥ 5,970 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,180 | In stock |
FMF-04-159-2 相关产品
| 产品描述 | FMF-04-159-2 is a potent covalent cell cycle protein-dependent kinase 14 (CDK14) inhibitor with IC₅₀ of 39.6 nM for CDK14 and 256 nM for CDK2.FMF-04-159-2 is able to reduce α-synuclein (α-Syn ) aggregation in neurons and plays a role in Parkinson's disease models, and also inhibits triple-negative breast cancer (TNBC) progression and metastasis by attenuating Wnt/β-catenin signaling. |
| 靶点活性 | CDK14-CyclinY:39.6 nM (in NanoBRET assay) , CDK2:256 nM (in NanoBRET assay), CDK14-CyclinY:39.6 nM, CDK2:256 nM |
| 体外活性 | FMF-04-159-2 可以抑制 HCT116细胞增殖,IC50 为 1,144±190 nM。[1] |
| 分子量 | 683.01 |
| 分子式 | C28H30Cl3N7O5S |
| CAS No. | 2364489-81-4 |
| Smiles | N(C(=O)C1=C(Cl)C=C(Cl)C=C1Cl)C=2C(C(NC3CCN(S(=O)(=O)C4=CC(NC(/C=C/CN(C)C)=O)=CC=C4)CC3)=O)=NNC2 |
| 密度 | 1.53 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 200 mg/mL (292.82 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (7.32 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容